How many drugs treat Rosacea?

Drug Landscape tracks 10 marketed treatments for Rosacea (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

What's the most recent regulatory action in Rosacea?

Most recent: Alphagan — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/rosacea.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Rosacea — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rosacea (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Rosacea, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Lotemax	LOTEPREDNOL ETABONATE	Bausch Health	Corticosteroid	Glucocorticoid receptor	1998-01-01
Alphagan	BRIMONIDINE	Senju Pharmaceutical Co., Ltd	alpha-Adrenergic Agonist	Alpha-2C adrenergic receptor	1996-01-01
Alphagan	BRIMONIDINE TARTRATE	Senju Pharmaceutical Co., Ltd	alpha-Adrenergic Agonist	Alpha-2C adrenergic receptor	1996-01-01
Azelex	AZELAIC ACID	Leo Pharma As	azelaic acid	3-oxo-5-alpha-steroid 4-dehydrogenase 2	1995-01-01
Flarex	FLUOROMETHOLONE ACETATE	Harrow Health	Corticosteroid	Glucocorticoid receptor	1986-01-01
Vantobra	Tobramycin Sulfate	Pfizer	tobramycin	Taste receptor type 2 member 20	1974-01-01
Fml	FLUOROMETHOLONE	AbbVie	Corticosteroid	Glucocorticoid receptor	1972-01-01
Medrifar	MEDRYSONE	AbbVie	Corticosteroid	Glucocorticoid receptor	1969-01-01
Metro I.V. In Plastic Container	METRONIDAZOLE	Baxter	Nitroimidazole Antimicrobial [EPC]		1963-01-01
Decadron	dexamethasone	Generic (originally Merck)	Corticosteroid [EPC]	Annexin A1, Interleukin-4, Androgen receptor	1958-10-30

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-05-07 — Alphagan · FDA · approved · US
2026-04-16 — Alphagan · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Rosacea:

Cite this brief

Drug Landscape (2026). Rosacea — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/rosacea. Accessed 2026-06-10.

Rosacea full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing